Events

  • 01/06/2026
    Bridging Science Across Europe and Beyond
  • 11/19/2025
    WuXi AppTec Receives Frost & Sullivan’s 2025 Global Company of the Year Award in the CRDMO Industry
  • 10/30/2025
    CHEManager | WuXi AppTec: A Partner for Innovation
  • 10/28/2025
    WuXi AppTec Looks to Extend CRDMO Platform to Saudi Arabia as It Signs Strategic MoUs with NEOM and Ministry of Health
  • 10/26/2025
    WuXi AppTec Achieves Strong Double-Digit Growth in Revenue and Profit for Q1-Q3 2025; Backlog for Continuing Operations Up 41.2% YoY; Further Raises 2025 Full-year Guidance
  • 10/26/2025
    WuXi AppTec Unveils Modernized Logo, Reflecting Continued Evolution as a Global Healthcare Partner
  • 10/16/2025
    STAT | The end of the undruggable: Targeted protein degradation therapies open new frontiers in cancer care
  • 10/16/2025
    BioWorld | 25 Years of Impact: How WuXi AppTec is Enabling the Development of Innovative Therapeutics
  • 05/23/2024
    WuXi AppTec Breaks Ground on New Site in Singapore to Better Support Global Customers
  • January 13, 2026 1:00 PM-6:00 PM PST
    San Francisco
    WuXi Global Forum 2026
  • September 9, 2025 - September 18, 2025
    Basel, Boston, Copenhagen, and San Diego
    WuXi Science Forums
  • July 27, 2025 - July 31, 2025
    Toronto, Canada
    AAIC 2025
  • July 21, 2025 - July 21, 2025
    London, UK
    21st RSC Nucleic Acids Forum

New webinars are coming soon. Please check back regularly!
Find our most recent webinars, please scroll down.

  • Strategies for Screening and Characterizing Targeted Covalent Inhibitors

    With advancements in drug design, there is resurging interest in drugs that form covalent bonds with their targets, often referred to as targeted covalent inhibitors (TCIs). In this webinar, experts discuss innovative approaches to screen for covalent binders, strategies for the synthesis of covalent warheads, and assays to optimize the ADME/DMPK properties of these molecules.
    This webinar offers a comprehensive perspective on strategies that are crucial for accelerating research focused on covalent drug discovery.
  • Emerging Modalities in Drug Discovery

    In this webinar, we will present the latest advances and challenges facing researchers focused on new and emerging modalities in drug discovery. Topics will include targeted protein degradation, targeted covalent inhibitors, and nucleic acid therapeutics. Our expert speaker, Dr. Tao Guo, will discuss solutions for addressing the complexities in designing, synthesizing, and optimizing these molecules, with an added focus on the special modifications and delivery systems needed for siRNAs and ASOs.

How can we help?

Get in touch with an expert.

Contact us